Quantcast

Latest Antipsychotic Stories

2014-07-07 23:00:59

Launch of the Risperdal Lawsuits for Gynecomastia Page Comes as Hundreds of Plaintiffs Seek Compensation for Gynecomastia, a Condition Marked by the Excessive Growth of Male Breast Tissue, Which is Allegedly Caused by Risperdal. Chicago IL (PRWEB) July 07, 2014 The Oliver Law Group P.C. a harmful drug law firm, announces that they have launched a Risperdal lawsuit for Gynecomastia page in response to the growing Risperdal gynecomastia litigation underway in Pennsylvania state court. Court...

2014-06-27 23:01:53

The Firm is representing a number of men and boys in Risperdal lawsuits that claim use of the atypical antipsychotic medication caused gynecomastia (male breast growth). New York, New York (PRWEB) June 27, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that a newly released study has linked Risperdal to low bone mass in children. The study, which was presented earlier this month at the American...

2014-06-26 23:02:56

The Firm represents Risperdal lawsuit clients in claims that allege the antipsychotic medication caused men and boys to develop gynecomastia. Rockville Centre, NY (PRWEB) June 26, 2014 The Rottenstein Law Group LLP, a national law firm that specializes in personal injury cases filed by plaintiffs with claims of harm stemming from dangerous drugs and defective medical devices, announces the launch of a new website dedicated exclusively to helping men who have been injured by the atypical...

2014-06-25 23:02:50

The Firm is representing a number of Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the medication. New York, NY (PRWEB) June 25, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) that allege the antipsychotic drug caused men and boys to develop gynecomastia, or male breast growth, continue to mount in courts around the U.S., Bernstein Liebhard LLP reports. On June 12, 2014, a 24-year-old California man filed suit...

2014-06-23 12:29:42

Data Highlight Physician and Payer Receptivity to Emerging Agents for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., June 23, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. psychiatrists are receptive to novel adjunctive therapies to antidepressants for treatment-resistant depression (TRD) and would prescribe Otsuka/Lundbeck's emerging atypical antipsychotic brexpiprazole to a mean 12 percent of their drug-treated...

2014-06-20 23:09:40

The San Diego personal injury lawyers of The Law Office of Melinda J. Helbock, A.P.C. are investigating potential lawsuits on behalf of boys and men who developed gynecomastia after using Risperdal. San Diego, California (PRWEB) June 20, 2014 According to a recent study, use of atypical antipsychotics in children is increasing in Australia and other countries. According to the study, more than 12,600 children under the age 19 are using antipsychotics, and the most commonly prescribed drug...

2014-06-16 08:27:34

Takeda and Lundbeck to Present Late-breaker at International College of Neuropsychopharmacology World Congress VANCOUVER, British Columbia, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated the effect of Brintellix 10-20 mg/d on aspects of cognitive function, using an objective neuropsychological test (the Digit Symbol Substitution Test or DSST) associated with executive...

2014-06-15 23:01:05

The Firm is actively filing Risperdal lawsuits on behalf of men and young boys who allegedly developed gynecomastia, a condition categorized by male breast growth, after use of the antipsychotic. New York, NY (PRWEB) June 15, 2014 A consolidated litigation involving Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) is continuing to move forward in Pennsylvania state court, where an upcoming status conference is scheduled to take place next month, Bernstein Liebhard LLP reports....

2014-06-12 12:26:31

Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON, Mass., June 12, 2014 /PRNewswire/ -- Decision Resources Group finds that three therapies, Teva's Huntexil, Auspex's SD-809 and Raptor's Procysbi, will likely receive regulatory approval for Huntington's disease (HD) in the United States and the EU5 markets (Germany, France, Italy, Spain and United...

2014-06-11 23:02:08

The Firm is representing numerous boys and men in Risperdal lawsuits that allege use of the antipsychotic drug caused gynecomastia, or male breast growth. New York, New York (PRWEB) June 11, 2014 Janssen Pharmaceuticals, a division of Johnson & Johnson and a defendant in hundreds of Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) pending in a Pennsylvania mass tort proceeding, is attempting to block a bid by plaintiffs to revive punitive damage claims in cases that allege...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'